Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Guanfacine is an α2-adrenergic receptor (α2-AR) agonist with Ki values of 93, 1,380, and 3,890 nM for α2A-, α2B-, and α2C-ARs, respectively, in a radioligand binding assay.1 It has EC50 values of 52, 288, and 602 nM for α2A-, α2B-, and α2C-ARs, respectively, for stimulated [35S]GTPγS binding. It also binds to imidazoline receptor 1 (Ki = 19 nM in a radioligand binding assay).2 Guanfacine (0.3-5 mg/kg) binds to adrenergic receptors in the central nervous system and lowers blood pressure in hypertensive rats in a dose-dependent manner.3 It also improves spatial working memory deficits induced by hypobaric hypoxia in rats.4 Formulations containing guanfacine are used in the treatment of high blood pressure and attention deficit hyperactivity disorder (ADHD).
WARNING This product is not for human or veterinary use.
1. Ligand efficacy and potency at recombinant α2 adrenergic receptors: Agonist-
2. QSAR study of imidazoline antihypertensive drugs. Bioorg. Med. Chem. 16(15), 7134-7140 (2008).
3. Pharmacology of guanfacine. Br. J. Clin. Pharmacol. 10(Suppl 1), 21S-24S (1980).
4. Guanfacine is an effective countermeasure for hypobaric hypoxia-